China Pharma Holdings (CPHI) Return on Capital Employed Growth (1y) (2012 - 2026)
China Pharma Holdings (CPHI) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 89.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 448.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -1,715.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 999.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 9,717.00 |
| 10 | China Pharma Holdings | 18.56 Mn | 18.39 Mn | 285,487.00 | 714.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 714.00 |
| Dec 31, 2025 | 795.00 |
| Sep 30, 2025 | 3,059.00 |
| Jun 30, 2025 | 1,786.00 |
| Mar 31, 2025 | 126.00 |
| Dec 31, 2024 | -446.00 |
| Sep 30, 2024 | -2,661.00 |
| Jun 30, 2024 | -1,887.00 |
| Mar 31, 2024 | -402.00 |
| Dec 31, 2023 | 1,442.00 |
| Sep 30, 2023 | 6,642.00 |
| Jun 30, 2023 | 2,562.00 |
| Mar 31, 2023 | 1,762.00 |
| Dec 31, 2022 | 600.00 |
| Sep 30, 2022 | -2,985.00 |
| Jun 30, 2022 | 1,759.00 |
| Mar 31, 2022 | 255.00 |
| Dec 31, 2021 | -235.00 |
| Sep 30, 2021 | 15,180.00 |
| Jun 30, 2021 | 12,767.00 |